Institut Regional Du Cancer De Montpellier — Clinical Trial Site

249 Registered trials

106 Currently recruiting

Organisation

Institut Regional Du Cancer De Montpellier

Location

Montpellier Cedex 5, France

Identifier

ORG-100011308

Address

208 Avenue Des Apothicaires, 34298, France

Departments

-
/
#1002: Pneumologie onco-thoracique
1406: Nuclear Medicine
1506:Medical Oncology
2160: Médecine Nucléaire
2303: Oncologie Medicale
2304: Oncologie Medicale
2322 Oncology Medical
250003: Service d'Oncologie Médicale
25004: Oncologie Medicale - Cancerolo
33011: Oncologie Medicale
404: Oncologie Medicale - Cancerolo
9452:Oncologie Medicale
Breast Oncology
Cardiology
Centre d'Essais Cliniques de Phase Précoce (CLIP2)
Chirurgie Digestive
Chirurgie gynécologique
CRCICM Vald'Aurélie
Département d'Oncologie Médicale
Département d’Anesthésie Réanimation
Département d’oncologie médicale
Département de chirurgie oncologique
Department d'Oncologie Médicale
Department of Medical Oncology
digestif
Digestive Oncology
Digestive surgery
Early Clinical Trial Unit - Medical Oncology
FRA0801: Oncologie Medicale
Gastroenterology
Gynaecologic Oncology
Gynecological surgery
Head of early clinical trial unit
Hépato-gastroentérologie et oncologie digestive
Hepatogastroenterology
Hérault
ICM Val d'Aurelle
Médecin nucléaire
Médecine nucléaire
Médecine Nucléaire/ Oncologie Digestive
medecine nuclear department
Medical oncologist
Medical Oncology
Medical Oncology Department
Medical Oncology Service
N/A
NA
Nuclear medicine
Nuclear Medicine Unit
Onclogie médicale
Onco-gynecologie et senologie
Oncogynecologie et senologie
Oncologie
Oncologie médicale
Oncologue
Oncology
Oncology clinic
oncology department
Pneumologie et Oncologie Thoracique
Pneumonology
Pole de Radiotherapie Oncologique
Pulmonology and Thoracic oncology
radiation onclogy
Radiothérapie
Radiotherapie oncologique
Radiotherapy
Radiotherapy department
Radiotherapy for pediatrics
Radiotherapy Oncology
Service d'oncologie
Service d'oncologie médicale
Service d’Oncologie Médicale
Service de Chirurgie Digestive
Service de Pneumologie
Service Oncologie medicale
Surgery
Surgical Oncology
Thoracic oncology
UEPP
Val D'Aurelle - Department Medical Oncology

Clinical trials at this site (249)

Search interface

Early detection of triple negative breast cancer relapse (CUPCAKE) Not authorised

2022-501562-22-00 Triple-negative breast cancer (TNBC) patients at high r 4
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer Pending

2024-515339-30-00 Ovarian Cancer 4
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy Pending

2024-515340-23-00 Colon cancer 4
Quality of life and neurocognitive functioning in diffuse low-grade glioma patients treated with Temozolomide: feasibility study - TEMOIN Pending

2024-516918-37-00 Diffuse low-grade gliomas 4
PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients … Pending

2024-519753-11-00 Resectable borderline pancreatic adenocarcinoma 4
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( R… Pending

2024-519818-31-01 Endometrial Cancer Advanced, Recurrent, Metastatic, or 5
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizu… Pending

2025-521587-35-00 Metastatic colorectal cancer 5
Testing two different drugs (sacituzumab-govitecan and trastuzumab-deruxtecan) combinations prescribed in an alterning pattern to patients w… Pending

2025-521909-40-00 Patients with metastatic or locally advanced HER2-low t 4
A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Pending

2025-523576-23-00 Unresectable Stage III non-small cell lung cancer witho 5
Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m… Pending

2025-524408-30-01 Metastatic hormone-sensitive prostate cancer 5
Staging of gastric cancers by PET-FAPI Pending

2025-524434-25-00 gastric cancer 4
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which has Spread and Caused Significant Body Weight Lo… Recruiting

2025-522093-36-00 Cancer cachexia 10 2026-05-20
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants with Platinum-Resistant (Part A) and Platinum-Sensitive (Part B… Recruiting

2025-522255-25-00 Fallopian Tube Neoplasms 5 2026-05-18
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Pretreated Unresectable Locally Advanced or Metastatic 10 2026-05-08
Phase 3 study comparing ivonescimab alone or ivonescimab with ligufalimab versus pembrolizumab for the first-line treatment of recurrent and… Recruiting

2025-522996-27-00 recurrent and/or metastatic squamous cell carcinoma of 5 2026-05-05
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting

2023-508047-40-00 Ovarian cancer 5 2026-04-30
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC Recruiting

2025-522867-13-00 Non Small Cell Lung Cancer 4 2026-04-27
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib plus Ribociclib plus Fulvestrant Versus Placebo plus Ribociclib plus Fulve… Recruiting

2025-523013-28-00 Endocrine-Resistant Hormone-Receptor-Positive, HER2-Neg 4 2026-04-07
LuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and… Recruiting

2023-508995-12-01 Recurrent or metastatic non-small cell lung cancer (NSC 4 2025-12-24
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 10 2025-11-28
A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab vs Chemotherapy plus Pembrolizumab as First-Line Treatment o… Recruiting

2023-508056-19-00 HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Profi 5 2025-10-02
BreAK CRC (001) trial Recruiting

2024-512011-45-00 Unresectable locally advanced or metastatic colorectal 7 2025-06-17
A study comparing niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma Recruiting

2024-513077-48-00 O6-methylguanine methyltransferase (MGMT) unmethylated 5 2024-12-19
Renal Adjuvant MultiPle Arm Randomised Trial (RAMPART) Recruiting

2024-513219-29-00 Renal Cell Carcinoma 5 2024-10-21